Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.47
-0.1100-6.96%
Post-market: 1.500.0300+2.04%19:05 EDT
Volume:217.14K
Turnover:320.40K
Market Cap:10.16M
PE:-0.61
High:1.55
Open:1.55
Low:1.44
Close:1.58
Loading ...

Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

GlobeNewswire
·
30 Jul

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

GlobeNewswire
·
25 Jul

Intelligent Bio Solutions announces new data on IFDDS

TIPRANKS
·
23 Jul

Intelligent Bio Solutions Inc - Plans to Enter U.S. Market in 2025

THOMSON REUTERS
·
23 Jul

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

GlobeNewswire
·
23 Jul

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

GlobeNewswire
·
15 Jul

Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo

GlobeNewswire
·
10 Jul

Intelligent Bio Solutions Inc. Announces New Compensation Terms with Salary Increases and Enhanced Severance Benefits for Top Executives

Reuters
·
04 Jul

BRIEF-Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Reuters
·
25 Jun

Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25

TIPRANKS
·
09 Jun

Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows

TIPRANKS
·
28 May

Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference

TIPRANKS
·
22 May

Intelligent Bio Solutions to showcase fingerprint drug testing at RISE25

TIPRANKS
·
22 May

Intelligent Bio Solutions Inc. Reports Q1 2025 Net Loss Decrease to $2.54M; Revenues Decline Slightly to $728.9K

Reuters
·
21 May

Intelligent Bio Solutions Reports 20% Revenue Growth and 91% Year-Over-Year Gross Profit Increase in Q3 2025

Reuters
·
14 May

Press Release: Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

Dow Jones
·
13 May

Intelligent Bio Solutions Q3 2025 EPS $(0.44) Up From $(1.43) YoY, Sales $728.87K Down From $823.80K YoY

Benzinga
·
13 May

EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%

Benzinga
·
13 May

BRIEF-Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 Million - SEC Filing

Reuters
·
12 Apr

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

GlobeNewswire
·
31 Mar